These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 36264887
1. Systemic treatment for severe atopic dermatitis in children: a case series. Cheirif-Wolosky O, Elizalde-Jiménez IG, Romero MTG. Bol Med Hosp Infant Mex; 2022; 79(5):310-317. PubMed ID: 36264887 [Abstract] [Full Text] [Related]
2. Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey. Totri CR, Eichenfield LF, Logan K, Proudfoot L, Schmitt J, Lara-Corrales I, Sugarman J, Tom W, Siegfried E, Cordoro K, Paller AS, Flohr C. J Am Acad Dermatol; 2017 Feb; 76(2):281-285. PubMed ID: 27855965 [Abstract] [Full Text] [Related]
3. Systemic Agents for Severe Atopic Dermatitis in Children. Notaro ER, Sidbury R. Paediatr Drugs; 2015 Dec; 17(6):449-57. PubMed ID: 26547214 [Abstract] [Full Text] [Related]
5. Mycophenolate mofetil therapy in adult patients with recalcitrant atopic dermatitis. Dias-Polak D, Bergman R, Avitan-Hersh E. J Dermatolog Treat; 2019 Feb; 30(1):49-51. PubMed ID: 29683760 [Abstract] [Full Text] [Related]
6. Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany. Schmitt J, Abraham S, Trautmann F, Stephan V, Fölster-Holst R, Homey B, Bieber T, Novak N, Sticherling M, Augustin M, Kleinheinz A, Elsner P, Weidinger S, Werfel T. J Dtsch Dermatol Ges; 2017 Jan; 15(1):49-59. PubMed ID: 27862987 [Abstract] [Full Text] [Related]
7. Systemic treatment of pediatric atopic dermatitis with azathioprine and mycophenolate mofetil. Waxweiler WT, Agans R, Morrell DS. Pediatr Dermatol; 2011 Jan; 28(6):689-694. PubMed ID: 21967657 [Abstract] [Full Text] [Related]
8. Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review. Roekevisch E, Spuls PI, Kuester D, Limpens J, Schmitt J. J Allergy Clin Immunol; 2014 Feb; 133(2):429-38. PubMed ID: 24269258 [Abstract] [Full Text] [Related]
9. [Current and upcoming treatments of adult atopic dermatitis]. Lacour JP. Ann Dermatol Venereol; 2017 Dec; 144 Suppl 5():VS29-VS37. PubMed ID: 29433635 [Abstract] [Full Text] [Related]
10. Systemic therapy of atopic dermatitis in children and adults. Simon D. Curr Probl Dermatol; 2011 Dec; 41():156-164. PubMed ID: 21576956 [Abstract] [Full Text] [Related]
11. Systemic anti-inflammatory treatment of atopic dermatitis during conception, pregnancy and breastfeeding: Interdisciplinary expert consensus in Northern Europe. Deleuran M, Dézfoulian B, Elberling J, Knutar I, Lapeere H, Lossius AH, Schuttelaar MLA, Stockman A, Wikström E, Bradley M, de Bruin-Weller M, Gutermuth J, Mandelin JM, Schmidt MC, Thyssen JP, Vestergaard C. J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):31-41. PubMed ID: 37818828 [Abstract] [Full Text] [Related]
12. Systemic treatment of children and adolescents with atopic dermatitis aged ≥2 years: a Delphi consensus project mapping expert opinion in Northern Europe. de Graaf M, Janmohamed SR, Schuttelaar MLA, Agner T, Alfonso JH, De Schepper S, Deleuran M, Despontin K, Elenius V, Ghislain PD, Huilaja L, Johansson EK, Kvenshagen BK, Mandelin JM, Olset H, Svensson A, van Tuyll van Serooskerken AM, Thyssen JP, Vestergaard C. J Eur Acad Dermatol Venereol; 2022 Nov; 36(11):2153-2165. PubMed ID: 35793471 [Abstract] [Full Text] [Related]
13. Atopic dermatitis: phototherapy and systemic therapy. Davis DM, Borok J, Udkoff J, Lio P, Spergel J. Semin Cutan Med Surg; 2017 Sep; 36(3):118-123. PubMed ID: 28895958 [Abstract] [Full Text] [Related]
15. Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres. Garritsen FM, Roekevisch E, van der Schaft J, Deinum J, Spuls PI, de Bruin-Weller MS. J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1905-12. PubMed ID: 25752497 [Abstract] [Full Text] [Related]
16. Drug survival rates and reasons for drug discontinuation in patients with atopic dermatitis: a retrospective study of adult outpatients. Pino Lopez J, Kromer C, Herr R, Schmieder A, Bayerl C, Schaarschmidt ML. Eur J Dermatol; 2021 Apr 01; 31(2):233-238. PubMed ID: 33871362 [Abstract] [Full Text] [Related]
17. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. Sidbury R, Davis DM, Cohen DE, Cordoro KM, Berger TG, Bergman JN, Chamlin SL, Cooper KD, Feldman SR, Hanifin JM, Krol A, Margolis DJ, Paller AS, Schwarzenberger K, Silverman RA, Simpson EL, Tom WL, Williams HC, Elmets CA, Block J, Harrod CG, Begolka WS, Eichenfield LF, American Academy of Dermatology. J Am Acad Dermatol; 2014 Aug 01; 71(2):327-49. PubMed ID: 24813298 [Abstract] [Full Text] [Related]
18. Management of severe atopic dermatitis in children. Tan AU, Gonzalez ME. J Drugs Dermatol; 2012 Oct 01; 11(10):1158-65. PubMed ID: 23134980 [Abstract] [Full Text] [Related]
19. [Severe adult atopic dermatitis: treatment with mycophenolate mofetil in 8 patients]. Ballester I, Silvestre JF, Pérez-Crespo M, Lucas A. Actas Dermosifiliogr; 2009 Dec 01; 100(10):883-7. PubMed ID: 20038365 [Abstract] [Full Text] [Related]
20. Adverse event monitoring in patients on oral systemic medications for inflammatory skin disease. Singh P, Silverberg JI. J Am Acad Dermatol; 2020 Jun 01; 82(6):1537-1539. PubMed ID: 32088273 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]